1. LBA4Efficacy and safety of entrectinib in patients with NTRK fusion-positive tumours: Pooled analysis of STARTRK-2, STARTRK-1, and ALKA-372-001. (25th November 2018) Authors: Demetri, G D; Paz-Ares, L; Farago, A F; Liu, S V; Chawla, S P; Tosi, D; Kim, E S; Blakely, C M; Krauss, J C; Sigal, D; Bazhenova, L; John, T; Besse, B; Wolf, J; Seto, T; Chow-Maneval, E; Multani, P S; Johnson, A; Simmons, B; Doebele, R C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗